The Board of Directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has authorized a buyback plan on March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.97 CNY | +1.48% |
|
+3.45% | -4.23% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 8.01B | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.